High mobility group proteins in sepsis
G Liang, Z He - Frontiers in Immunology, 2022 - frontiersin.org
Sepsis, a systemic inflammatory response disease, is the most severe complication of
infection and a deadly disease. High mobility group proteins (HMGs) are non-histone …
infection and a deadly disease. High mobility group proteins (HMGs) are non-histone …
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
P Wend, S Runke, K Wend, B Anchondo… - EMBO molecular …, 2013 - embopress.org
Wnt/β‐catenin signalling has been suggested to be active in basal‐like breast cancer.
However, in highly aggressive metastatic triple‐negative breast cancers (TNBC) the role of β …
However, in highly aggressive metastatic triple‐negative breast cancers (TNBC) the role of β …
Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1
K Liu, C Zhang, T Li, Y Ding, T Tu… - International …, 2015 - spandidos-publications.com
Let-7 is one of the earliest discovered microRNAs (miRNAs) and has been reported to
regulate self renewal and tumorigenicity of breast cancer cells. Let-7a is a member of this …
regulate self renewal and tumorigenicity of breast cancer cells. Let-7a is a member of this …
Extracellular HMGA1 promotes tumor invasion and metastasis in triple-negative breast cancer
O Méndez, V Peg, C Salvans, M Pujals… - Clinical Cancer …, 2018 - AACR
Purpose: The study of the cancer secretome suggests that a fraction of the intracellular
proteome could play unanticipated roles in the extracellular space during tumorigenesis. A …
proteome could play unanticipated roles in the extracellular space during tumorigenesis. A …
HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer
F Fu, T Wang, Z Wu, Y Feng, W Wang, S Zhou… - Cell Death & …, 2018 - nature.com
High-mobility group AT-hook1 (HMGA1, formerly HMG-I/Y), an architectural transcription
factor, participates in a number of tumor biological processes. However, its effect on cervical …
factor, participates in a number of tumor biological processes. However, its effect on cervical …
SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients
GD Song, Y Sun, H Shen, W Li - Tumor Biology, 2015 - Springer
Sex-determining region Y-related high mobility group box 4 (SOX4) has been proven to
serve as a critical role in cancer development and progression. However, little is known …
serve as a critical role in cancer development and progression. However, little is known …
Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis
Z Wang, S Liang, X Lian, L Liu, S Zhao, Q Xuan… - Scientific reports, 2015 - nature.com
Chemoresistance is a poor prognostic factor in breast cancer and is a major obstacle to the
successful treatment of patients receiving chemotherapy. However, the precise mechanism …
successful treatment of patients receiving chemotherapy. However, the precise mechanism …
Linking signaling pathways to transcriptional programs in breast cancer
Cancer cells acquire genetic and epigenetic alterations that often lead to dysregulation of
oncogenic signal transduction pathways, which in turn alters downstream transcriptional …
oncogenic signal transduction pathways, which in turn alters downstream transcriptional …
Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy
J Xu, X Zhao, X Liang, D Guo, J Wang, Q Wang… - Science …, 2024 - science.org
Lin28, a highly conserved carcinogenic protein, plays an important role in the generation of
cancer stem cells, contributing to the unfavorable prognosis of cancer patients. This RNA …
cancer stem cells, contributing to the unfavorable prognosis of cancer patients. This RNA …
Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
E Yang, J Cisowski, N Nguyen, K O'callaghan, J Xu… - Oncogene, 2016 - nature.com
As the majority of patients with basal-like breast carcinoma present with invasive, metastatic
disease that do not respond to available therapies, it is essential to identify new therapeutic …
disease that do not respond to available therapies, it is essential to identify new therapeutic …